Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Hansen Pharmaceutical(002412) the Revenue is 263.23 M (-2.25%);the EBIT is 58.35 M (-13.63%);the EPS is 0.0763 (+240.6%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.26B2.25%
----
----
EBIT
0.06B13.63%
----
----
EPS
0.0763240.63%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf